These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31577977)

  • 41. Discovery of 5,6-diaryl-1,2,4-triazines hybrids as potential apoptosis inducers.
    Fu DJ; Song J; Hou YH; Zhao RH; Li JH; Mao RW; Yang JJ; Li P; Zi XL; Li ZH; Zhang QQ; Wang FY; Zhang SY; Zhang YB; Liu HM
    Eur J Med Chem; 2017 Sep; 138():1076-1088. PubMed ID: 28763643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and Synthesis of 2-(5-Phenylindol-3-yl)benzimidazole Derivatives with Antiproliferative Effects towards Triple-Negative Breast Cancer Cells by Activation of ROS-Mediated Mitochondria Dysfunction.
    Wang M; Wu Y; Xu C; Zhao R; Huang Y; Zeng X; Chen T
    Chem Asian J; 2019 Aug; 14(15):2648-2655. PubMed ID: 31144429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis, and biological evaluation of new pyrazino[1,2-a]benzimidazole derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Azami Movahed M; Daraei B; Shahosseini S; Esfahanizadeh M; Zarghi A
    Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800265. PubMed ID: 30561073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis and biological evaluation of [1,2,3]triazolo[4,5-d]pyrimidine derivatives possessing a hydrazone moiety as antiproliferative agents.
    Li ZH; Yang DX; Geng PF; Zhang J; Wei HM; Hu B; Guo Q; Zhang XH; Guo WG; Zhao B; Yu B; Ma LY; Liu HM
    Eur J Med Chem; 2016 Nov; 124():967-980. PubMed ID: 27771599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis and biological evaluation of chrysin benzimidazole derivatives as potential anticancer agents.
    Wang Z; Deng X; Xiong S; Xiong R; Liu J; Zou L; Lei X; Cao X; Xie Z; Chen Y; Liu Y; Zheng X; Tang G
    Nat Prod Res; 2018 Dec; 32(24):2900-2909. PubMed ID: 29063798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis and biological evaluation of novel 2,4-diaminopyrimidine cinnamyl derivatives as inhibitors of FAK with potent anti-gastric cancer activities.
    Liu Y; Kong LJ; Li N; Liu YH; Jia MQ; Liu QG; Zhang SY; Song J
    Bioorg Chem; 2023 Dec; 141():106895. PubMed ID: 37797456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis and preliminary biological evaluation of 5,8-dihydropteridine-6,7-diones that induce apoptosis and suppress cell migration.
    Geng PF; Wang CC; Li ZH; Hu XN; Zhao TQ; Fu DJ; Zhao B; Yu B; Liu HM
    Eur J Med Chem; 2018 Jan; 143():1959-1967. PubMed ID: 29133051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and in vitro antitumor activity of 2-alkyl, 2-aryl, and 2-piperazinyl benzimidazole-4,7-dione derivatives.
    Ahn CM; Tak JA; Choi SJ
    Arch Pharm Res; 2000 Aug; 23(4):288-301. PubMed ID: 10976573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer.
    Bistrović A; Krstulović L; Harej A; Grbčić P; Sedić M; Koštrun S; Pavelić SK; Bajić M; Raić-Malić S
    Eur J Med Chem; 2018 Jan; 143():1616-1634. PubMed ID: 29133046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
    Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
    Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
    Lu X; Zhang H; Li X; Chen G; Li QS; Luo Y; Ruan BF; Chen XW; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(22):6827-32. PubMed ID: 22000948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microwave-Assisted Syntheses of Benzimidazole-Containing Selenadiazole Derivatives That Induce Cell-Cycle Arrest and Apoptosis in Human Breast Cancer Cells by Activation of the ROS/AKT Pathway.
    Liang Y; Zhou Y; Deng S; Chen T
    ChemMedChem; 2016 Oct; 11(20):2339-2346. PubMed ID: 27677422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
    Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells.
    Jin R; Xia Y; Chen Q; Li W; Chen D; Ye H; Zhao C; Du X; Shi D; Wu J; Liang G
    Drug Des Devel Ther; 2016; 10():979-95. PubMed ID: 27042000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and biological evaluation of novel 1-hydroxyl-3-aminoalkoxy xanthone derivatives as potent anticancer agents.
    Yang ZM; Huang J; Qin JK; Dai ZK; Lan WL; Su GF; Tang H; Yang F
    Eur J Med Chem; 2014 Oct; 85():487-97. PubMed ID: 25113877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, antitumor activity and SAR study of novel [1,2,4]triazino[4,5-a]benzimidazole derivatives.
    El-Nassan HB
    Eur J Med Chem; 2012 Jul; 53():22-7. PubMed ID: 22542105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel 5-Substituted 2-(Aylmethylthio)-4-chloro-N-(5-aryl-1,2,4-triazin-3-yl)benzenesulfonamides: Synthesis, Molecular Structure, Anticancer Activity, Apoptosis-Inducing Activity and Metabolic Stability.
    Żołnowska B; Sławiński J; Pogorzelska A; Szafrański K; Kawiak A; Stasiłojć G; Belka M; Ulenberg S; Bączek T; Chojnacki J
    Molecules; 2016 Jun; 21(6):. PubMed ID: 27338337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
    Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
    Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thiosemicarbazone-based lead optimization to discover high-efficiency and low-toxicity anti-gastric cancer agents.
    Zhang XH; Bo-Wang ; Tao YY; Ma Q; Wang HJ; He ZX; Wu HP; Li YH; Zhao B; Ma LY; Liu HM
    Eur J Med Chem; 2020 Aug; 199():112349. PubMed ID: 32438199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.